CRYOPORT INC (CYRX) — insider trading
Health Care · NASDAQ
CRYOPORT INC (CYRX) has 28 reported SEC Form 4 insider transactions in our data, including 8 open-market sales among the most recent 28 (latest 2026-06-11).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Option exercise / conversion (derivative) | 33,600 | $0.00 | $0 | Form 4 |
| 2026-06-11 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Open-market sale | 33,600 | $14.47 | $486.2K | Form 4 |
| 2026-06-11 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Option exercise / conversion | 33,600 | $4.80 | $161.3K | Form 4 |
| 2026-06-10 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Option exercise / conversion (derivative) | 1,400 | $0.00 | $0 | Form 4 |
| 2026-06-10 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Open-market sale | 1,400 | $15.23 | $21.3K | Form 4 |
| 2026-06-10 | ZECCHINI EDWARD J | Officer (Chief Digital and Tech Officer) | Option exercise / conversion | 1,400 | $4.80 | $6.7K | Form 4 |
| 2026-06-08 | Mandalam Ramkumar | Director | Open-market sale | 23,214 | $15.44 | $358.5K | Form 4 |
| 2026-06-05 | BADDOUR LINDA | Director | Grant / award / vesting (derivative) | 16,077 | $0.00 | $0 | Form 4 |
| 2026-06-05 | BADDOUR LINDA | Director | Grant / award / vesting | 10,350 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Mandalam Ramkumar | Director | Grant / award / vesting (derivative) | 16,077 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Mandalam Ramkumar | Director | Grant / award / vesting | 10,350 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Hariri Robert J | Director | Grant / award / vesting (derivative) | 16,077 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Hariri Robert J | Director | Grant / award / vesting | 10,350 | $0.00 | $0 | Form 4 |
| 2026-06-05 | HANCOCK DANIEL M | Director | Grant / award / vesting (derivative) | 16,077 | $0.00 | $0 | Form 4 |
| 2026-06-05 | HANCOCK DANIEL M | Director | Grant / award / vesting | 10,350 | $0.00 | $0 | Form 4 |
| 2026-06-04 | STEFANOVICH ROBERT | Officer (Chief Financial Officer) | Open-market sale | 169,427 | $16.27 | $2.76M | Form 4 |
| 2026-04-21 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion (derivative) | 104,007 | $0.00 | $0 | Form 4 |
| 2026-04-21 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion | 104,007 | $1.87 | $194.5K | Form 4 |
| 2026-04-06 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2026-04-06 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion | 50,000 | $1.87 | $93.5K | Form 4 |
| 2026-03-23 | Sawicki Mark W | Officer (Chief Scientific Officer) | Open-market sale | 1,341 | $8.18 | $11.0K | Form 4 |
| 2026-03-23 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-03-23 | SHELTON JERRELL | Director, Officer (President, CEO) | Option exercise / conversion | 25,000 | $1.87 | $46.8K | Form 4 |
| 2026-03-23 | SHELTON JERRELL | Director, Officer (President, CEO) | Open-market sale | 2,894 | $8.18 | $23.7K | Form 4 |
| 2026-03-23 | STEFANOVICH ROBERT | Officer (Chief Financial Officer) | Open-market sale | 1,094 | $8.18 | $8.9K | Form 4 |
| 2026-03-16 | ZECCHINI EDWARD J | Officer (See Remarks) | Open-market sale | 2,014 | $8.00 | $16.1K | Form 4 |
| 2026-03-14 | ZECCHINI EDWARD J | Officer (See Remarks) | Grant / award / vesting (derivative) | 63,965 | $0.00 | $0 | Form 4 |
| 2026-03-14 | ZECCHINI EDWARD J | Officer (See Remarks) | Grant / award / vesting | 21,322 | $0.00 | $0 | Form 4 |
Ask the chat about CYRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CRYOPORT INC (CYRX).
Last updated 2026-06-11 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.